retatrutide type 2 diabetes trial results 2024 2025 Tirzepatide vs. Retatrutide: Key Differences Explained Triple hormone receptor agonist retatrutide

Moreover, given that sex differences are relevant to the pathophysiological mechanisms of neurological diseases, future studies should include female and male subjects for comprehensive analysis

ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee

GLP-1 medicines in neurodegenerative diseases Extensive preclinical evidence illustrates the anti-inflammatory and neuroprotective properties of GLP-1 medicines across multiple models of neurodegenerative disease, particularly Alzheimers disease (AD) and Parkinsons disease (PD)

Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis